Omic analyses for drug target identification

Our goal is to identify potential drug targets of brain disorders (e.g., Alzheimer’s disease) through gene networks comprising disease-associated genes. Recent genomic studies have advanced our knowledge of the genetics of brain disorders and related traits, which could illuminate the pathogenesis of brain disorders. 
The new knowledge provides opportunities for genetic-based strategies for drug target identification. Bioinformatics analyses will be performed to prioritize drug targets and potential drugs for repurposing.